Foundation Fighting Blindness Opens Up Major Natural History Data for Retinal Disease Research

In a strong step toward open science and accelerated treatment development, the Foundation Fighting Blindness has made publicly available four years of de-identified patient data from its RUSH2A natural history study. The study tracks individuals with mutations in the USH2A gene—responsible for both non-syndromic retinitis pigmentosa (RP) and Usher syndrome type 2A—with the goal of improving how clinical trials in inherited retinal diseases are designed. Yahoo Finance What the RUSH2A Data Release Means The data covers more than 100 participants with USH2A mutations, followed over four years . It includes structural (imaging), functional (visual field / sensitivity), and mobility-related measures. Yahoo Finance By making this data open access for researchers , the Foundation is removing a longstanding barrier: access to robust natural history datasets. These datasets help companies and academic teams identify sensitive clinical endpoints , optimize trial design, and reduce risk in therapy development. Because USH2A-related diseases are a key target for multiple emerging therapies, the